These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37773049)

  • 1. Sarcopenic obesity: A new predictor of recipient liver regeneration after living donor liver transplantation?
    Rosenthal BE; Bittermann T
    Liver Transpl; 2024 Apr; 30(4):345-346. PubMed ID: 37773049
    [No Abstract]   [Full Text] [Related]  

  • 2. Sarcopenic obesity may predict worse liver regeneration after right graft living donor liver transplantation.
    Ali Deeb A; Settmacher U; Fritsch J; Dondorf F; Rohland O; Rauchfuß F
    Liver Transpl; 2024 Apr; 30(4):412-420. PubMed ID: 37548548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
    Kamo N; Kaido T; Hamaguchi Y; Okumura S; Kobayashi A; Shirai H; Yao S; Yagi S; Uemoto S
    Clin Nutr; 2019 Oct; 38(5):2202-2209. PubMed ID: 30482562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study.
    Olthoff KM; Emond JC; Shearon TH; Everson G; Baker TB; Fisher RA; Freise CE; Gillespie BW; Everhart JE
    Liver Transpl; 2015 Jan; 21(1):79-88. PubMed ID: 25065488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenic obesity with metabolic syndrome: a newly recognized entity following living donor liver transplantation.
    Choudhary NS; Saigal S; Saraf N; Mohanka R; Rastogi A; Goja S; Menon PB; Mishra S; Mittal A; Soin AS
    Clin Transplant; 2015 Mar; 29(3):211-5. PubMed ID: 25594826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
    Isıklar A; Safer U; Binay Safer V; Yiyit N
    Clin Nutr; 2019 Apr; 38(2):964-965. PubMed ID: 30739808
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation.
    Kaido T; Tamai Y; Hamaguchi Y; Okumura S; Kobayashi A; Shirai H; Yagi S; Kamo N; Hammad A; Inagaki N; Uemoto S
    Nutrition; 2017 Jan; 33():195-198. PubMed ID: 27649861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
    Kim YR; Park S; Han S; Ahn JH; Kim S; Sinn DH; Jeong WK; Ko JS; Gwak MS; Kim GS
    Sci Rep; 2018 May; 8(1):7157. PubMed ID: 29740069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of the musculoadipose status in the assessment of the risk profile before liver transplantation].
    Deeb AA; Rauchfuß F; Settmacher U
    Chirurgie (Heidelb); 2024 Aug; 95(8):632-637. PubMed ID: 38829546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply - Letter to the Editor - Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
    Kaido T; Kamo N; Uemoto S
    Clin Nutr; 2019 Apr; 38(2):967. PubMed ID: 30739810
    [No Abstract]   [Full Text] [Related]  

  • 11. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation.
    Marcos A; Fisher RA; Ham JM; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Fulcher AS; Posner MP
    Transplantation; 2000 Apr; 69(7):1375-9. PubMed ID: 10798757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myosteatosis, the More Significant Predictor of Outcome: An Analysis of the Impact of Myosteatosis, Sarcopenia, and Sarcopenic Obesity on Liver Transplant Outcomes in Johannesburg, South Africa.
    Irwin NEA; Fabian J; Hari KR; Lorentz L; Mahomed A; Botha JF
    Exp Clin Transplant; 2021 Sep; 19(9):948-955. PubMed ID: 34387151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of sarcopenia with graft failure and mortality in patients undergoing living donor liver transplantation.
    Sim JH; Kwon HM; Kim KW; Ko YS; Jun IG; Kim SH; Kim KS; Moon YJ; Song JG; Hwang GS
    Liver Transpl; 2022 Aug; 28(8):1345-1355. PubMed ID: 35243771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARCOPENIA, OBESITY AND SARCOPENIC OBESITY IN LIVER TRANSPLANTATION: A BODY COMPOSITION PROSPECTIVE STUDY.
    Anastácio LR; Ferreira LG; Ribeiro HS; Diniz KGD; Lima AS; Correia MITD; Vilela EG
    Arq Bras Cir Dig; 2019; 32(2):e1434. PubMed ID: 31038559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia Affects Liver Regeneration and Long-Term Survival Rate After Living-Donor Liver Transplantation in Patients With Hepatocellular Carcinoma.
    Wu MY; Yeh CH; Liao CC; Chen CL; Wang CC; Lin CC; Chang WC; Cheng YF; Ou HY
    Transplant Proc; 2024 Apr; 56(3):573-580. PubMed ID: 38326205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver regeneration in donors and adult recipients after living donor liver transplantation.
    Haga J; Shimazu M; Wakabayashi G; Tanabe M; Kawachi S; Fuchimoto Y; Hoshino K; Morikawa Y; Kitajima M; Kitagawa Y
    Liver Transpl; 2008 Dec; 14(12):1718-24. PubMed ID: 19025926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Preoperative Sarcopenia, Malnutrition and Functional status on Postoperative Morbidity Following Liver Transplantation.
    Prakash K; Sam AF; K N; Tandon N
    Prog Transplant; 2022 Dec; 32(4):345-350. PubMed ID: 36253720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Status of Adult Living Donor Liver Transplantation in the United States: Results from the Adult-To-Adult Living Donor Liver Transplantation Cohort Study.
    Abu-Gazala S; Olthoff KM
    Gastroenterol Clin North Am; 2018 Jun; 47(2):297-311. PubMed ID: 29735025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? A multicentre analysis.
    Croome KP; Hernandez-Alejandro R; Parker M; Heimbach J; Rosen C; Nagorney DM
    HPB (Oxford); 2015 Jun; 17(6):477-84. PubMed ID: 25728543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
    Lodewick TM; van Nijnatten TJ; van Dam RM; van Mierlo K; Dello SA; Neumann UP; Olde Damink SW; Dejong CH
    HPB (Oxford); 2015 May; 17(5):438-46. PubMed ID: 25512239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.